Hood River Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-238,670
| Closed | -$34.8M | – | 146 |
|
|
2022
Q2 | $34.8M | Buy |
238,670
+7,133
| +3% | +$1.04M | 1.38% | 22 |
|
|
2022
Q1 | $27.5M | Sell |
231,537
-68,435
| -23% | -$8.11M | 0.91% | 41 |
|
|
2021
Q4 | $41.3M | Buy |
299,972
+214,452
| +251% | +$29.6M | 1.24% | 27 |
|
|
2021
Q3 | $11.9M | Sell |
85,520
-231,828
| -73% | -$32.2M | 0.37% | 75 |
|
|
2021
Q2 | $30.8M | Sell |
317,348
-4,739
| -1% | -$460K | 0.92% | 41 |
|
|
2021
Q1 | $22M | Buy |
322,087
+113,141
| +54% | +$7.73M | 0.71% | 57 |
|
|
2020
Q4 | $17.9M | Buy |
208,946
+3,326
| +2% | +$285K | 0.59% | 70 |
|
|
2020
Q3 | $13.4M | Sell |
205,620
-20,662
| -9% | -$1.34M | 0.58% | 69 |
|
|
2020
Q2 | $16.5M | Buy |
+226,282
| New | +$16.5M | 0.74% | 51 |
|